Physician

Giselle Baquero Caranama, M.D.

According to 2025 Medicare claims, Giselle Caranama, M.D. (NPI: 1437383213) practices cardiology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is MAIKAI HEARTS LLC (NPI: 1750029211) and primary practice location at 96817-2362.

Caranama's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 772 traditional Medicare patients, billed 6,761 HCPCS/CPT codes, and received $572,501 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,309 prescription claims across 707 beneficiaries totaling $1,748,953 in drug costs, led by Entresto (Sacubitril/Valsartan). Open Payments data shows 67 records totaling $2,519. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $30,354 to $572,501. Similarly, Part D prescription costs have risen steadily, from $3,790 to $1,748,953. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$286K$573K2017 Medicare payment: $30,354 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $64,373 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $12,263 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $26,103 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $44,646 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $144,984 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $371,766 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $572,501 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
201783261$30,354
2018180556$64,373
201981165$12,263
202083212$26,103
2021149461$44,646
20225111,615$144,984
20237394,267$371,766
20247726,761$572,501

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$874K$1.7M2015 Drug cost: $3,790 (USD; Tot_Drug_Cst)2016 Drug cost: $4,756 (USD; Tot_Drug_Cst)2017 Drug cost: $338 (USD; Tot_Drug_Cst)2018 Drug cost: $13,419 (USD; Tot_Drug_Cst)2019 Drug cost: $14,378 (USD; Tot_Drug_Cst)2020 Drug cost: $5,542 (USD; Tot_Drug_Cst)2021 Drug cost: $19,581 (USD; Tot_Drug_Cst)2022 Drug cost: $277,529 (USD; Tot_Drug_Cst)2023 Drug cost: $1,442,843 (USD; Tot_Drug_Cst)2024 Drug cost: $1,748,953 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152769$3,790
20162043$4,756
2017N/R19$338
201844145$13,419
201951228$14,378
20201730$5,542
202165144$19,581
20224201,090$277,529
20236084,233$1,442,843
20247075,309$1,748,953

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function591638$130
93978Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts413418$120
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more470736$94
93356Heart muscle strain imaging416450$31
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report492564$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EntrestoSacubitril/Valsartan39129,080$526,734
EliquisApixaban33125,255$471,214
XareltoRivaroxaban23416,975$302,416
VascepaIcosapent Ethyl1219,730$110,069
JardianceEmpagliflozin554,120$81,150

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.67$2,519ABIOMED
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Giselle Baquero Caranama, M.D.?

Tedicare shows public-source Medicare data for Giselle Baquero Caranama, M.D. (NPI 1437383213), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Giselle Baquero Caranama, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Giselle Baquero Caranama, M.D.?

Giselle Baquero Caranama, M.D. is linked to MAIKAI HEARTS LLC (billing NPI 1750029211) in the available physician profile data.

Does Giselle Baquero Caranama, M.D. have Open Payments data?

Giselle Baquero Caranama, M.D. has 67 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.